APA (7th ed.) Citation

P, T., ED, P., AY, C., LK, N., RA, H., AB, G., . . . Cannon, C. P. (2007). Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE). American Journal of Cardiology, 99(10), 1389. https://doi.org/10.1016/j.amjcard.2006.12.066

Chicago Style (17th ed.) Citation

P, Tricoci, et al. "Timing of Glycoprotein IIb/IIIa Inhibitor Use and Outcomes Among Patients with Non-ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (results from CRUSADE)." American Journal of Cardiology 99, no. 10 (2007): 1389. https://doi.org/10.1016/j.amjcard.2006.12.066.

MLA (9th ed.) Citation

P, Tricoci, et al. "Timing of Glycoprotein IIb/IIIa Inhibitor Use and Outcomes Among Patients with Non-ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (results from CRUSADE)." American Journal of Cardiology, vol. 99, no. 10, 2007, p. 1389, https://doi.org/10.1016/j.amjcard.2006.12.066.